Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Selective NNMT inhibitor substrate site-targeting mechanism with IC50 of 1.2 M in reference assay conditions Selectivity over related methyltransferases does not significantly affect other enzymes in the NAD salvage pathway at research concentrations Reduces intracellular 1-methylnicotinamide (1-MNA) formation in cell-based assay models Studied in adipocyte, liver, and skeletal muscle cell-based research models examining NNMT-dependent methylation pathway dynamics Referenced at Sigma-Aldrich (SML2832) and in peer-reviewed literature on NNMT enzyme biology Membrane-permeable quaternary quinolinium scaffold studied for intracellular NNMT target engagement in cell-based models Batch and lot identifiers on all labeling for full laboratory documentation compliance Research Background 5-Amino-1MQ was first characterized as a selective NNMT inhibitor in published research literature in 2018
Consistency Matters Regular Schedule: Taking Sermorelin at the same time each day ensures steady hormone levels
Do not self-medicate
Confirm benzyl alcohol concentration (0.9% is standard
5-Amino-1MQ and NAD+ are studied together to investigate combined NNMT inhibition and direct NAD+ supplementation effects on adipocyte metabolism and cellular energy pathways
If you are facing fertility challenges, PCOS, or fibroids
